{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:49:43Z","timestamp":1791596983539,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["CZZ21004"],"award-info":[{"award-number":["CZZ21004"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["XTZ20021"],"award-info":[{"award-number":["XTZ20021"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["CZZ23001"],"award-info":[{"award-number":["CZZ23001"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["CZZ24011"],"award-info":[{"award-number":["CZZ24011"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771274"],"award-info":[{"award-number":["31771274"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370680"],"award-info":[{"award-number":["82370680"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31270361"],"award-info":[{"award-number":["31270361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270364"],"award-info":[{"award-number":["32270364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.isci.2026.117174","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:56:07Z","timestamp":1786589767000},"page":"117174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Mingling","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5853-3139","authenticated-orcid":false,"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117174_bib1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41581-021-00462-y","article-title":"Trajectories of Kidney Function in Diabetes: A Clinicopathological Update","volume":"17","author":"Oshima","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.isci.2026.117174_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling Pathways of Chronic Kidney Diseases, Implications for Therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.117174_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nefro.2022.07.008","article-title":"Glucagon-Like Peptide 1(GLP-1) Receptor Agonists in the Management of the Patient with Type 2Diabetes Mellitus and Chronic Kidney Disease: An Approach for the Nephrologist","volume":"43","author":"Cases","year":"2023","journal-title":"Nefrologia"},{"key":"10.1016\/j.isci.2026.117174_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1046130","article-title":"Semaglutide Ameliorates Metabolism and Hepatic Outcomes in an NAFLD Mouse Model","volume":"13","author":"Niu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2026.117174_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-Like Peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.isci.2026.117174_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117174_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108036","article-title":"Psychotropic Effects of GLP-1R Agonists","volume":"222","author":"Bucciarelli","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.117174_bib8","doi-asserted-by":"crossref","first-page":"F1647","DOI":"10.1152\/ajprenal.00082.2009","article-title":"Regulation of Na+\/H+ Exchanger NHE3 by Glucagon-Like Peptide 1 Receptor Agonist Exendin-4 in Renal Proximal Tubule Cells","volume":"297","author":"Carraro-Lacroix","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.isci.2026.117174_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2018.03.004","article-title":"The Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Attenuates Renal Fibrosis","volume":"131","author":"Li","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.117174_bib10","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3892\/mmr.2014.2555","article-title":"Liraglutide Ameliorates Renal Injury in Streptozotocin-Induced Diabetic Rats by Activating Endothelial Nitric Oxide Synthase Activity via The Downregulation of the Nuclear Factor-\u03bab Pathway","volume":"10","author":"Zhou","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.isci.2026.117174_bib11","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3390\/biomedicines10071661","article-title":"Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease","volume":"10","author":"Dalb\u00f8ge","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.117174_bib12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/ph18081130","article-title":"Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and GLP-1 RAs","volume":"18","author":"Rabbani","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.isci.2026.117174_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12020-024-03998-8","article-title":"Comparison of the Effects of Liraglutide, Tirzepatide, and Retatrutide on Diabetic Kidney Disease in db\/db Mice","volume":"87","author":"Ma","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.isci.2026.117174_bib14","first-page":"27","article-title":"Proteomic Identification of 14-3-3zeta as an Adapter for IGF-1 and AKT\/GSK-3beta Signaling and Survival of Renal Mesangial Cells","volume":"3","author":"Singh","year":"2006","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.isci.2026.117174_bib15","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.109","article-title":"Failure to Phosphorylate AKT in Podocytes From Mice with Early Diabetic Nephropathy Promotes Cell Death","volume":"73","author":"Tejada","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2026.117174_bib16","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1681\/ASN.2004090802","article-title":"Peroxisome Proliferator-Activated Receptor Beta\/Delta Exerts a Strong Protection from Ischemic Acute Renal Failure","volume":"16","author":"Letavernier","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2026.117174_bib17","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.cmet.2025.10.014","article-title":"Body-Wide Multi-Omic Counteraction of Aging with GLP-1R Agonism","volume":"37","author":"Huang","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2026.117174_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.601325","article-title":"Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.117174_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MNH.0000000000000782","article-title":"Ageing, Cellular Senescence and Chronic Kidney Disease: Experimental Evidence","volume":"31","author":"Tan","year":"2022","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.isci.2026.117174_bib20","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1681\/ASN.2014080752","article-title":"Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective","volume":"26","author":"Hodgin","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2026.117174_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.14336\/AD.2020.0703","article-title":"Aging and Renal Disease: Old Questions for New Challenges","volume":"12","author":"Chou","year":"2021","journal-title":"Aging Dis."},{"key":"10.1016\/j.isci.2026.117174_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ki.2012.65","article-title":"The Implications of Anatomical and Functional Changes of the Aging Kidney: With an Emphasis on the Glomeruli","volume":"82","author":"Glassock","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2026.117174_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb0203","article-title":"Cellular Senescence Inhibits Renal Regeneration After Injury in Mice, with Senolytic Treatment Promoting Repair","volume":"13","author":"Mylonas","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.117174_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12079-017-0434-2","article-title":"Cellular Senescence in the Aging and Diseased Kidney","volume":"12","author":"Valentijn","year":"2018","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.isci.2026.117174_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nefro.2019.03.001","article-title":"Burden, Access, and Disparities in Kidney Disease","volume":"40","author":"Crews","year":"2020","journal-title":"Nefrologia"},{"key":"10.1016\/j.isci.2026.117174_bib26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A Single Number for Advocacy and Communication-Worldwide More Than 850 Million Individuals Have Kidney Diseases","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2026.117174_bib27","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3390\/cells12121581","article-title":"The Role of Inflammation in CKD","volume":"12","author":"Kadatane","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.117174_bib28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/ijms22010408","article-title":"Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences","volume":"22","author":"Panizo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117174_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12609","article-title":"Understanding Cell Cycle and Cell Death Regulation Provides Novel Weapons Against Human Diseases","volume":"281","author":"Wiman","year":"2017","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.isci.2026.117174_bib30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ndt\/gfu230","article-title":"Cell Cycle Arrest and the Evolution of Chronic Kidney Disease from Acute Kidney Injury","volume":"30","author":"Canaud","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.isci.2026.117174_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13098-025-01736-2","article-title":"Semaglutide and Adenosine Alleviate Obesity-Induced Kidney Injury, with Observed Modulation of the Txnip\/NLRP3 Pathway","volume":"17","author":"Wang","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.isci.2026.117174_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108045","article-title":"History of Glucagon-Like Peptide-1 Receptor Agonists","volume":"222","author":"Darwish","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.117174_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","article-title":"Tirzepatide, a Dual GIP\/GLP-1 Receptor Co-agonist for the Treatment of Type 2 Diabetes with Unmatched Effectiveness Regrading Glycaemic Control and Body Weight Reduction","volume":"21","author":"Nauck","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.isci.2026.117174_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177095","article-title":"The Power of Three: Retatrutide's Role in Modern Obesity and Diabetes Therapy","volume":"985","author":"Abdul-Rahman","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.isci.2026.117174_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/jdi.14336","article-title":"Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity","volume":"16","author":"Bae","year":"2025","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.isci.2026.117174_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117174_bib37","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","article-title":"Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease","volume":"132","author":"Burnier","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.isci.2026.117174_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117174_bib39","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.HYP.0000037969.41360.CC","article-title":"PPARalpha Activator Effects on Ang II-induced Vascular Oxidative Stress and Inflammation","volume":"40","author":"Diep","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.isci.2026.117174_bib40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the Progression of Chronic Kidney Disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.isci.2026.117174_bib41","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jfma.2025.03.027","article-title":"Pathophysiology and Blood Pressure Measurements of Hypertension in the Elderly","volume":"124","author":"Chen","year":"2025","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.isci.2026.117174_bib42","first-page":"87","article-title":"[Electrolyte and Acid-Base Balance Disorders in Advanced Chronic Kidney Disease]","volume":"28","author":"Alc\u00e1zar Arroyo","year":"2008","journal-title":"Nefrologia"},{"key":"10.1016\/j.isci.2026.117174_bib43","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1096\/fj.14-265983","article-title":"Alteration of Gut Microbiota by Vancomycin and Bacitracin Improves Insulin Resistance via Glucagon-Like Peptide 1 in Diet-Induced Obesity","volume":"29","author":"Hwang","year":"2015","journal-title":"Faseb J."},{"key":"10.1016\/j.isci.2026.117174_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41387-024-00303-4","article-title":"L-Valine Is a Powerful Stimulator of GLP-1 Secretion in Rodents and Stimulates Secretion Through ATP-Sensitive Potassium Channels and Voltage-Gated Calcium Channels","volume":"14","author":"Modvig","year":"2024","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.isci.2026.117174_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5582\/ddt.2024.01061","article-title":"Effect of switching from dulaglutide to tirzepatide on blood glucose and renal function","volume":"18","author":"Ishimura","year":"2024","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.isci.2026.117174_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41421-024-00700-0","article-title":"Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide","volume":"10","author":"Li","year":"2024","journal-title":"Cell Discov."},{"key":"10.1016\/j.isci.2026.117174_bib47","article-title":"GLP-1 Receptor Agonists Alleviate Diabetic Kidney Injury via \u03b2-Klotho-Mediated Ferroptosis Inhibition","volume":"12","author":"Tian","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.117174_bib48","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/jdi.12956","article-title":"Protein Kinase C and Protein Kinase A Are Involved in the Protection of Recombinant Human Glucagon-Like Peptide-1 on Glomeruli and Tubules in Diabetic Rats","volume":"10","author":"Yin","year":"2019","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.isci.2026.117174_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113877","article-title":"GLP-1\/GIP Dual Agonist Tirzepatide Normalizes Diabetic Nephropathy via PI3K\/AKT Mediated Suppression of Oxidative Stress","volume":"146","author":"Tian","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2026.117174_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154873","article-title":"Fufang Shenhua Tablet Inhibits Renal Fibrosis by Inhibiting PI3K\/AKT","volume":"116","author":"Li","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.isci.2026.117174_bib51","first-page":"65","article-title":"Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease","volume":"54","author":"Guan","year":"2002","journal-title":"Minerva Urol. Nefrol."},{"key":"10.1016\/j.isci.2026.117174_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153818","article-title":"Oleic acid alleviates LPS-induced acute kidney injury by restraining inflammation and oxidative stress via the Ras\/MAPKs\/PPAR-\u03b3 signaling pathway","volume":"94","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.isci.2026.117174_bib53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2023.12.024","article-title":"Downregulation of the Kidney Glucagon Receptor, Essential for Renal Function and Systemic Homeostasis, Contributes to Chronic Kidney Disease","volume":"36","author":"Wang","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2026.117174_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1523-1755.2002.00430.x","article-title":"Epithelial-Mesenchymal Transition of Tubular Epithelial Cells in Human Renal Biopsies","volume":"62","author":"Rastaldi","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2026.117174_bib55","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH783>3.0.CO;2-P","article-title":"Distribution of Fibronectin Isoforms in Human Renal Disease","volume":"193","author":"Van Vliet","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.isci.2026.117174_bib56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41586-019-1112-8","article-title":"p38\u03b3 is essential for cell cycle progression and liver tumorigenesis","volume":"568","author":"Tom\u00e1s-Loba","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117174_bib57","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1074\/jbc.M512536200","article-title":"Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1","volume":"281","author":"Spaziani","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.117174_bib58","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1080\/15384101.2015.1032636","article-title":"Cell Aging and Kidney Repair","volume":"14","author":"Susnik","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.isci.2026.117174_bib59","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1038\/s41467-022-34287-5","article-title":"Circular RNA circBNC2 Inhibits Epithelial Cell G2-M Arrest to Prevent Fibrotic Maladaptive Repair","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117174_bib60","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1681\/ASN.0000000953","article-title":"PACS-2 Alleviates Kidney Fibrosis by Inhibiting Tubular Epithelial Cell G2\/M Arrest through CDKL1 Kinase","volume":"37","author":"Li","year":"2026","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2026.117174_bib61","doi-asserted-by":"crossref","first-page":"F215","DOI":"10.1152\/ajprenal.00548.2007","article-title":"Protein kinase B\/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo","volume":"295","author":"Kattla","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.isci.2026.117174_bib62","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1681\/ASN.2009050479","article-title":"The ubiquitin-like protein FAT10 mediates NF-kappaB activation","volume":"21","author":"Gong","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2026.117174_bib63","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1111\/j.1440-1797.2005.00456.x","article-title":"Protective effect of peroxisome proliferator activated receptor gamma agonists on diabetic and non-diabetic renal diseases","volume":"10","author":"Chung","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.isci.2026.117174_bib64","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.apsb.2023.11.020","article-title":"Design and Discovery of a Highly Potent Ultralong-Acting GLP-1 and Glucagon Co-agonist for Attenuating Renal Fibrosis","volume":"14","author":"Zhao","year":"2024","journal-title":"Acta Pharm. Sin. B"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226025526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226025526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:58:17Z","timestamp":1791593897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226025526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589004226025526"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117174","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117174"}}